February 2025

  • MMWR LogoLeonard J, Harker EJ, Szablewski CM, et al. Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners — United States, September 2024. MMWR Morb Mortal Wkly Rep 2025;74:50–52. DOI: http://dx.doi.org/10.15585/mmwr.mm7404a2.
  • MMWR LogoGargano JW, Stefanos R, Dahl RM, et al. Trends in Cervical Precancers Identified Through Population-Based Surveillance — Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008–2022. MMWR Morb Mortal Wkly Rep 2025;74:96–101. DOI: http://dx.doi.org/10.15585/mmwr.mm7406a4.
  • MMWR LogoFrutos AM, Cleary S, Reeves EL, et al. Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025. MMWR Morb Mortal Wkly Rep 2025;74:83–90. DOI: http://dx.doi.org/10.15585/mmwr.mm7406a2
  • MMWR LogoFazal A, Reinhart K, Huang S, et al. Reports of Encephalopathy Among Children with Influenza-Associated Mortality — United States, 2010–11 Through 2024–25 Influenza Seasons. MMWR Morb Mortal Wkly Rep 2025;74:91–95. DOI: http://dx.doi.org/10.15585/mmwr.mm7406a3.

January 2025

  • MMWR LogoIssa AN, Wodi AP, Moser CA, Cineas S. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2025. MMWR Morb Mortal Wkly Rep 2025;74:26–29. DOI: http://dx.doi.org/10.15585/mmwr.mm7402a2.
  • MMWR LogoWodi AP, Issa AN, Moser CA, Cineas S. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2025. MMWR Morb Mortal Wkly Rep 2025;74:30–33. DOI: http://dx.doi.org/10.15585/mmwr.mm7402a3.

December 2024

  • MMWR LogoSandul AL, Rapposelli K, Nyendak M, Kim M. Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19–59 Years — United States, 2024. MMWR Morb Mortal Wkly Rep 2024;73:1106. DOI: http://dx.doi.org/10.15585/mmwr.mm7348a3.
  • MMWR LogoBlack CL, Kriss JL, Razzaghi H, et al. Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2023. MMWR Morb Mortal Wkly Rep 2023;72:1377–1382. DOI: http://dx.doi.org/10.15585/mmwr.mm7251a4.

November 2024

  • MMWR LogoReses HE, Segovia G, Dubendris H, et al. Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024. MMWR Morb Mortal Wkly Rep 2024;73:1052–1057. DOI: http://dx.doi.org/10.15585/mmwr.mm7346a2.
  • MMWR LogoKriss JL, Black CL, Razzaghi H, et al. Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults — United States, Fall 2024. MMWR Morb Mortal Wkly Rep 2024;73:1044–1051. DOI: http://dx.doi.org/10.15585/mmwr.mm7346a1.

October 2024

  • MMWR LogoBell J, Meng L, Barbre K, et al. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season. MMWR Morb Mortal Wkly Rep 2024;73:966–972. DOI: http://dx.doi.org/10.15585/mmwr.mm7343a2.

September 2024

  • MMWR LogoPanagiotakopoulos L, Moulia DL, Godfrey M, et al. Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025. MMWR Morb Mortal Wkly Rep 2024;73:819–824. DOI: http://dx.doi.org/10.15585/mmwr.mm7337e2.

April 2024

March 2024

February 2024

January 2024

Archives

December 2023

November 2023

October 2023

September 2023

August 2023

July 2023

June 2023

May 2023

April 2023

March 2023

February 2023

January 2023

December 2022

November 2022

October 2022

September 2022

August 2022

July 2022

June 2022

May 2022

NIH launches clinical trial of Epstein-Barr virus vaccine. Read more.

April 2022

March 2022

  • MMWR LogoPlumb ID, Feldstein LR, Barkley E, et al. Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022. MMWR Morb Mortal Wkly Rep. ePub: 12 April 2022. DOI: http://dx.doi.org/10.15585/mmwr.mm7115e2external icon.
  • MMWR Logo Fowlkes AL, Yoon SK, Lutrick K, et al. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022. MMWR Morb Mortal Wkly Rep 2022;71:422–428. DOI: http://dx.doi.org/10.15585/mmwr.mm7111e1external icon.
  • MMWR Logo Wallace M, Moulia D, Blain AE, et al. The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022. MMWR Morb Mortal Wkly Rep 2022;71:416–421. DOI: http://dx.doi.org/10.15585/mmwr.mm7111a4external icon.
  • MMWR Logo Taylor CA, Whitaker M, Anglin O, et al. COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022. MMWR Morb Mortal Wkly Rep. ePub: 18 March 2022. DOI: http://dx.doi.org/10.15585/mmwr.mm7112e2.
  • MMWR Logo Tenforde MW, Self WH, Gaglani M, et al. Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022. MMWR Morb Mortal Wkly Rep. ePub: 18 March 2022. DOI: http://dx.doi.org/10.15585/mmwr.mm7112e1.
  • MMWR Logo Hause AM, Baggs J, Marquez P, et al. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022. MMWR Morb Mortal Wkly Rep. ePub: 1 March 2022. DOI: http://dx.doi.org/10.15585/mmwr.mm7109e2.
  • MMWR Logo Klein NP, Stockwell MS, Demarco M, et al. Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022. MMWR Morb Mortal Wkly Rep. ePub: 1 March 2022. DOI: http://dx.doi.org/10.15585/mmwr.mm7109e3external icon.

January 2022

CDC Immunization Works Newsletter

December 2021

November 2021

October 2021

October 2020

September 2020

August 2020

July 2020

June 2020

May 2020

April 2020

March 2020

February 2020

January 2020